Bret Jensen | TalkMarkets | Page 5
Full-time Investor
Bret Jensen was chief investment strategist from 2008-2011 for Simplified Asset Management (S.A.M.), a small long/short hedge fund based in Miami. The fund was in top 5% of long/short hedge funds for total return in its first full year (2009) as ranked by Hedgeco fund database (more than 450 funds ...more

All Contributions

Latest Posts
65 to 80 of 170 Posts
<<< 1 ... 3 4 5 6 7 ... 11 >>>
Avoid These 2 Stocks In 2016
With valuations stretched beyond rational belief, these two stocks have little room to run up but plenty to crash down. These are two stocks your portfolio would be better off avoiding in 2016.
4 Cheap Stocks To Buy That Will Beat The Market In 2016
Avoid below average returns by investing in these four safe stocks with good valuations and strong dividends. If 2016 is indeed a repeat of 2015, the dividends from these stocks alone will beat the market.
Three Best Large-Cap Growth Stocks To Buy And Hold Forever
Since bottoming in late September, the biotech complex has posted approximate 15% returns. If historical patterns hold, investors should count on several quarters of outperformance until the sector hits another predictable hiccup.
Buy These 2 Likely Biotech Takeover Targets
EGRX, BDSI: their cutting-edge drug portfolios and profitable relationships with industry heavyweights make these two rapidly advancing biotech companies prime takeover targets.
3 Reasons This Rally Won’t Last
After a couple of rough weeks of sledding, the market rebounded this week. The S&P 500 posted a gain of 3.3% over the past five trading sessions, its best weekly gain since mid-December of 2014.
3 Safe Stocks Making Big Profits From Cheap Oil
Invest in these three safe large-cap stocks with confidence as they are part of a small group of stocks actually performing well in this troubling market. With true earnings growth and a boost from cheap oil, these stocks will shine in 2016.
Zogenix: A Small Biotech Stock To Put On Your Radar
One small cap biotech/pharma stock that looks like it has bottomed recently and that I have in my own portfolio is Zogenix (NASDAQ: ZGNX). It is worth to put it on your radar.
How Much Upside Is Left For Isis Pharmaceuticals?
It would not be surprising given the current state of the M&A market and its evolving pipeline; that ISIS is gobbled up in a takeover in the foreseeable future.
Protect Your Portfolio With These 2 Safe Growth Stocks
Growing revenue in the mid-teens, trading at reasonable valuations, and increasing dividends by double-digits these two stocks are perfect buys if you’re worried about your portfolio and will be consistently safe performers even in a tough market.
3 Stocking Stuffer Stocks For A Happy New Year
Bret Jensen is giving you your first Christmas present early this year by sharing three stocks that he owns and loves that offer tremendous investing opportunities. Invest in these three stocks that are already in motion to have a great 2016.
BioDelivery Sciences: Undervalued With Buyout Potential
BioDelivery Sciences International has a market capitalization of just over $300 million, enough cash on hand to fund itself through at least mid-2017 and has one approved product on the market and one more on the way.
2 Turnaround Stocks That Can Double Your Money In 2016
The worst is behind them, and 2016 is shaping up to be a great year for these two stocks. They are back on track to grow their earnings and when they execute on their turnaround strategies their stock prices will return to former highs.
2 Promising Biotech Stocks For More Than A Beer But Less Than A Martini
The sector had dipped a toe into “official” bear market territory back in late September.
Insiders Are Loading Up On These 3 Attractive Small Cap Stocks
The October rally in stocks seems to have passed over the high beta parts of the market, keeping many small cap stocks’ share prices low.
Why You Should Pass On Investing In This $3.00 Drug Stock
I dived in deeper myself before making any decision to recommend this company as a holding. Catalyst Pharmaceuticals (CPRX) goes for just over $3.00 a share and has been getting some positive attention from analysts recently.
3 American Companies Cashing In On The Rise Of The Chinese Consumer
These three stocks are the only safe way to invest in the explosion of the Chinese middle class. They have strong brands and excellent marketing firming their positions as market leaders in soon the largest consumer market in the entire world.
65 to 80 of 170 Posts
<<< 1 ... 3 4 5 6 7 ... 11 >>>